Publicacions
-
Forero-Castro M, Robledo C, Benito R, Bodega-Mayor I, Rapado I, Hernández-Sánchez M, Abáigar M, Maria Hernández-Sánchez J, Quijada-Álamo M, María Sánchez-Pina J, Sala-Valdés M, Araujo-Silva F, Kohlmann A, Luis Fuster J, Arefi M, de Las Heras N, Riesco S, Rodríguez JN, Hermosín L, Ribera J, Camós-Guijosa M, Ramírez M, de Heredia Rubio CD, Barragán E, Martínez J, Ribera JM, Fernández-Ruiz E and Hernández-Rivas JM.
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
BRITISH JOURNAL OF CANCER . 117(2): 256-265. Nº de cites: 32
-
Cela E, Bellón JM, de la Cruz M, Beléndez C, Berrueco R, Ruiz-Llobet A, Elorza I, Díaz de Heredia C, Cervera A, Vallés G, Salinas JA, Coll MT, Bermúdez M, Prudencio M, Argilés B and Vecilla C.
National registry of hemoglobinopathies in Spain (REPHem)
PEDIATRIC BLOOD & CANCER . 64(7): . Nº de cites: 34
-
Barba P, Dapena JL, Montesinos P and Rives-Solà S.
Asparaginase use for the treatment of acute lymphoblastic leukemia
MEDICINA CLINICA . 148(5): 225-231. Nº de cites: 5
-
Reina-Castillón J, Pujol R, López-Sánchez M, Rodríguez-Santiago B, Aza-Carmona M, González JR, Casado JA, Bueren JA, Sevilla J, Badel I, Català-Temprano A, Beléndez C, Dasí MÁ, Díaz de Heredia C, Soulier J, Schindler D, Pérez-Jurado LA and Surrallés J.
Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia.
blood advances . 1(5): 319-329. Nº de cites: 18
-
Monsonís Cabedo M, Rives-Solà S, Noguera-Julián A, Urrea M, Cruz-Martínez O and Gene-Giralt A.
Assessment of anaerobic blood cultures in pediatric oncology patients
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(1): 33-36. Nº de cites: 5
-
Pascual C, Trenchs-Sainz de la Maza V, Hernández-Bou S, Català-Temprano A, Valls-Lafon A and Luaces-Cubells C.
Outcomes and infectious etiologies of febrile neutropenia in non-immunocompromised children who present in an emergency department
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 35(10): 1667-1672. Nº de cites: 18
-
Català-Temprano A, Pastor-Anglada M, Caviedes-Cárdenas L, Malatesta R, Rives-Solà S, Vega-García N, Camós-Guijosa M and Fernández-Calotti P.
FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia
Oncotarget . 7(31): 49786-49799. Nº de cites: 12
-
Rovira N, Noguera-Julián A, Rives-Solà S, Berrueco R, Lahoz R and Fortuny-Guasch C.
Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants
EUROPEAN JOURNAL OF PEDIATRICS . 175(7): 1013-1017. Nº de cites: 9
-
Bautista F, Gallego S, Cañete A, Mora J, Diaz de Heredia C, Cruz-Martínez O, Fernández JM, Rives-Solà S, Madero L, Castel V, Cela ME, Ramírez G, Sábado C, Acha T, Astigarraga I, Sastre A, Muñoz A, Guibelalde M and Moreno L.
Landscape of early clinical trials for childhood and adolescence cancer in Spain
CLINICAL & TRANSLATIONAL ONCOLOGY . 18(7): 708-713. Nº de cites: 6
-
Gianesin K, Noguera-Julián A, Zanchetta M, Del Bianco P, Petrara MR, Freguja R, Rampon O, Fortuny-Guasch C, Camós-Guijosa M, Mozzo E, Giaquinto C and De Rossi A.
Premature aging and immune senescence in HIV-infected children
Aids . 30(9): 1363-1373. Nº de cites: 75